基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02616 基石药业-B

未开盘 03-19 16:08:15

6.920

-0.330

-4.55%

最高7.240	最低6.830	成交量887.90万
今开7.240	昨收7.250	日振幅5.66%
总市值102.14亿	流通市值102.14亿	总股本14.76亿
成交额6,194万	换手率0.60%	流通股本14.76亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"基石药业-B","latestPrice":6.92,"timestamp":1773907695005,"preClose":7.25,"halted":0,"volume":8879000,"delay":0,"changeRate":-0.045517241379310354,"floatShares":1476000000,"shares":1476000000,"eps":-0.071467,"marketStatus":"未开盘","change":-0.33,"latestTime":"03-19 16:08:15","open":7.24,"high":7.24,"low":6.83,"amount":61944736,"amplitude":0.056552,"askPrice":6.92,"askSize":9000,"bidPrice":6.9,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.28,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":0,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":7.25,"openAndCloseTimeList":[[1773883800000,1773892800000],[1773896400000,1773907200000]],"volumeRatio":0.9700326658240528,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02616","defaultTab":"news","newsList":[{"id":"2620401384","title":"基石药业-B(02616)将携三项自主研发管线成果亮相国际学术舞台","url":"https://stock-news.laohu8.com/highlight/detail?id=2620401384","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620401384?lang=zh_cn&edition=full","pubTime":"2026-03-18 07:18","pubTimestamp":1773789521,"startTime":"0","endTime":"0","summary":"智通财经APP讯，基石药业-B(02616)发布公告，本公司三项自主研发管线的临床前研究成果成功入选2026年美国癌症研究协会(AACR)年会壁报展示环节。该会议是全球癌症研究领域最具影响力的学术会议之一，本届年会将于2026年4月17日至22日在美国加利福尼亚州圣地牙哥会议中心隆重举行。相关研究摘要将于2026 年4月3日在AACR官方期刊《Cancer Research》上发表。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2619616724","title":"每日卖空追踪 | 基石药业-B 03月13日卖空量成交151.55万股，卖空比例为18.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619616724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619616724?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:30","pubTimestamp":1773390632,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间03月13日，跌0.28%，卖空量成交151.55万股，较上一交易日减少54.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163451a6bd1cd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163451a6bd1cd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2617350920","title":"港股异动 | 基石药业-B(02616)再涨超9% 获纳入富时中国小盘股 三抗临床研究快速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2617350920","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617350920?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:47","pubTimestamp":1772768878,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B(02616)再涨超9%，截至发稿，涨9.18%，报7.02港元，成交额7081.36万港元。消息面上，根据全球权威指数编制机构富时罗素（FTSE Russell）发布的富时全球股票指数系列（FTSE GEIS）半年度审议调整结果，基石药业成功获纳入富时中国小盘股指数成份股。相关调整将于2026年3月20日收盘后正式生效。国元国际指出，公司的PD-1/VEGF/CTLA-4 三抗安全性及疗效数据优秀，当前正在进行全球多中心二期临床研究，目前已入组200例患者，随着今年3月开始临床数据的逐步公布，有望达成重磅BD。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4535","BK4581","BK4614","TZA","BK4534","02616","IWN","UWM","BK4585","MNQmain","IWO","RWM","BK4588","BK4550","BK1161","SRTY","TWM","BK1574"],"gpt_icon":0},{"id":"1151451437","title":"港股异动 | 生物技术板块走强，药捷安康暴涨35%，百奥赛图涨14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151451437","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151451437?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:32","pubTimestamp":1772767952,"startTime":"0","endTime":"0","summary":"圣诺医药涨超11%，荣昌生物、基石药业涨超8%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5137f1e9d165d819bc52e4abac894dbc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","02257","09995","02616","02315"],"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617066845?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势，三生制药 涨9.83%，基石药业-B涨6.84%，荣昌生物涨6.31%，映恩生物-B涨5.98%，四环医药涨5.76%，恒瑞医药涨5.77%，君圣泰医药-B涨5.58%，康诺亚-B涨5.31%，复宏汉霖涨5.02%。交银国际表示，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","09995","HK0000252160.HKD","BK1600","BK1515","BK1574","01276","BK1583","HK0000500386.USD","LU2543165471.USD","01530","LU0359202008.SGD","LU2328871848.SGD","06978","02162","00460","HK0000252152.HKD","HK0000306701.USD","LU1969619763.USD","02511","02616","LU0359201612.USD","159992","HK0000306685.HKD","BK1191","HK0000320264.USD","HK0000320223.HKD","LU0359201885.HKD","LU1023057109.AUD","09606","BK1161","BK1587","HK0000165453.HKD","BK1593"],"gpt_icon":0},{"id":"1188526290","title":"基石药业-B（02616）披露2月股份变动月报 新增发行8,532股","url":"https://stock-news.laohu8.com/highlight/detail?id=1188526290","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188526290?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:52","pubTimestamp":1772704341,"startTime":"0","endTime":"0","summary":"基石药业-B于2026年3月5日发布截至2026年2月28日的股份变动月报。公告显示，公司法定股本维持在2,000,000,000股，对应注册股本USD 200,000，报告期内未见增减变动。公司普通股方面，于2026年1月底已发行股份1,476,006,841股，2月新增发行8,532股，期末已发行股份合计1,476,015,373股。公告显示，当月并无库藏股，高管确认截至本月底公司已满足香港联交所规定的公众持股量要求。公司声明以上变动均遵照香港联交所《上市规则》及相关法律法规办理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"gpt_icon":0},{"id":"2617733596","title":"港股异动 | 基石药业-B(02616)涨超12% 公司自研PD-1/VEGF/CTLA-4三抗有望达成重磅BD","url":"https://stock-news.laohu8.com/highlight/detail?id=2617733596","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617733596?lang=zh_cn&edition=full","pubTime":"2026-03-05 10:36","pubTimestamp":1772678196,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B涨超12%，截至发稿，涨12.71%，报6.65港元，成交额3695.43万港元。消息面上，基石药业-B此前发布公告称，公司核心资产CS2009用于晚期实体瘤的II期新药临床试验申请已经获得美国食品药品监督管理局批准。国元证券发布研报称，基石药业-B核心产品CS2009临床数据优异，安全性显著优于同类疗法，在IO经治NSCLC患者中ORR达17.6%，DCR达82.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PD","BK4588","LU1169590202.USD","BK4023","02616","LU1169589451.USD","VXUS","BK1574","BK4585","VT","BK1161"],"gpt_icon":0},{"id":"2616837678","title":"每日卖空追踪 | 基石药业-B 03月03日卖空量成交135.95万股，卖空比例为17.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616837678","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616837678?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526634,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间03月03日，跌3.99%，卖空量成交135.95万股，较上一交易日减少74.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163437a445cc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163437a445cc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2616388233","title":"【券商聚焦】国元国际予基石药业-B(02616)买入评级 指公司有望达成重磅BD","url":"https://stock-news.laohu8.com/highlight/detail?id=2616388233","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616388233?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:46","pubTimestamp":1772433966,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国元国际发研报指，基石药业-B 是创新驱动型生物医药企业，公司已成功上市4款创新药、获批16项新药上市申请以及9项适应症。当前正在进行全球多中心二期临床研究，地点包括澳大利亚和中国，目前已入组200例患者，美国II期临床已经获得FDA批准。疗效数据尚在成熟中，在墙报数据截止日后的随访期间，整体ORR提升至14.3%。CS5001是首个在实体瘤及淋巴瘤中均显示出临床抗肿瘤活性的ROR1ADC。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975711","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"gpt_icon":0},{"id":"2614882728","title":"港股异动 | 基石药业-B(02616)尾盘涨超8% 舒格利单抗III期非小细胞肺癌新适应症获英国MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614882728","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614882728?lang=zh_cn&edition=full","pubTime":"2026-02-27 15:54","pubTimestamp":1772178879,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B尾盘涨超8%，截至发稿，涨6.73%，报6.66港元，成交额9312.3万港元。消息面上，基石药业此前宣布，舒格利单抗的新适应症申请已获英国MHRA批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因子受体敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期NSCLC成人患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4134","VT","III","VXUS","02616","BK4588","BK4585","BK1574"],"gpt_icon":0},{"id":"2614097970","title":"基石药业-B盘中异动 下午盘大幅跳水5.14%报6.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614097970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614097970?lang=zh_cn&edition=full","pubTime":"2026-02-26 15:22","pubTimestamp":1772090579,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘15时22分，基石药业-B股票出现异动，股价快速下挫5.14%。截至发稿，该股报6.280港元/股，成交量1080.05万股，换手率0.73%，振幅5.14%。资金方面，该股资金流入3085.5万港元，流出3279.19万港元。基石药业-B股票所在的生物技术行业中，整体跌幅为5.26%。其相关个股中，百奥赛图-B、思路迪医药股份、药捷安康-B涨幅较大，振幅较大的相关个股有三叶草生物-B、百奥赛图-B、药捷安康-B，振幅分别为11.96%、11.38%、9.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226152259a7214bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226152259a7214bca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2614057191","title":"每日卖空追踪 | 基石药业-B 02月25日卖空量成交157.1万股，卖空比例为8.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614057191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614057191?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008236,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月25日，涨4.09%，卖空量成交157.1万股，较上一交易日减少14.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163442a4c675db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163442a4c675db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2614777939","title":"港股异动 | 基石药业-B(02616)再涨超6% 月内涨超25% 舒格利单抗III期NSCLC获英国正式批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614777939","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614777939?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:04","pubTimestamp":1771999477,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B再涨超6%，月内累计涨幅已超25%。消息面上，2月23日，基石药业宣布，其PD-L1抗体舒格利单抗针对III期非小细胞肺癌的新适应症，已正式取得英国药品和医疗保健用品管理局的批准。此外，基石药业核心资产CS2009用于晚期实体瘤的II期临床试验IND申请近期获得FDA批准。CS2009用于晚期实体瘤的II期新药临床试验申请获美国食品药品监督管理局批准，标志着这一创新免疫疗法的全球开发取得重要进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","VT","BK4588","III","02616","BK1574","VXUS","BK4585","BK4134"],"gpt_icon":0},{"id":"2613796954","title":"基石药业-B02月24日主力净流入732.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796954","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613796954?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920945,"startTime":"0","endTime":"0","summary":"02月24日, 基石药业-B股价涨5.12%，报收6.36元，成交金额7642.2万元，换手率0.82%，振幅7.44%，量比1.26。基石药业-B今日主力资金净流入732.5万元，上一交易日主力净流出192.4万元。该股近5个交易日上涨14.98%，主力资金累计净流入2719.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入7324.2万元，其中净流入天数为17日。该股主力净额占比0.08%，港股市场排名83/2720。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161941a4c22511&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161941a4c22511&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2613750044","title":"港股基石药业-B涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613750044","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613750044?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:50","pubTimestamp":1771901446,"startTime":"0","endTime":"0","summary":"每经AI快讯，基石药业-B(02616.HK)涨超5%，截至发稿，涨5.12%，报6.36港元，成交额2393.21万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602243652474013.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602243652474013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","VXUS","BK1161","VT","BK1574","BK4588","02616"],"gpt_icon":0},{"id":"2613750586","title":"港股异动 | 基石药业-B(02616)涨超5% 舒格利单抗III期非小细胞肺癌新适应症获英国MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2613750586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613750586?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:30","pubTimestamp":1771900210,"startTime":"0","endTime":"0","summary":"消息面上，基石药业昨日公布，舒格利单抗的新适应症申请已获英国药品和医疗保健用品管理局批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因数受体敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期小细胞肺癌成人患者。继欧盟委员会批准后，舒格利单抗III期NSCLC新适应症再获英国MHRA批准，这是该产品在英国获得的第二个适应症批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","02616","VT","BK4585","BK4134","BK4588","BK1161","BK1574","VXUS"],"gpt_icon":0},{"id":"2613624657","title":"每日卖空追踪 | 基石药业-B 02月23日卖空量成交64.95万股，卖空比例为8.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613624657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613624657?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835432,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月23日，跌2.1%，卖空量成交64.95万股，较上一交易日减少65.1%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163423a4be7df5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163423a4be7df5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2613624417","title":"基石药业-B02月23日主力净流出192.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613624417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613624417?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834544,"startTime":"0","endTime":"0","summary":"02月23日, 基石药业-B股价跌2.10%，报收6.05元，成交金额4851.1万元，换手率0.53%，振幅6.63%，量比0.74。基石药业-B今日主力资金净流出192.4万元，上一交易日主力净流入170.5万元。该股近5个交易日上涨8.04%，主力资金累计净流入3129.0万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入6476.3万元，其中净流入天数为16日。该股主力净额占比0.02%，港股市场排名2615/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161840a71559c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161840a71559c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1161","BK1574"],"gpt_icon":0},{"id":"2613027209","title":"基石药业-B(02616)：舒格利单抗III期小细胞肺癌新适应症获英国MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2613027209","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613027209?lang=zh_cn&edition=full","pubTime":"2026-02-23 08:17","pubTimestamp":1771805849,"startTime":"0","endTime":"0","summary":"基石药业-B(02616)发布公告，舒格利单抗的新适应症申请已获英国药品和医疗保健用品管理局(MHRA)批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因数受体(EGFR)敏感突变或ALK、ROS1基因组变异、在含铂放化疗(CRT)后未出现疾病进展的、不可切除的III期小细胞肺癌(NSCLC)成人患者。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4134","BK1574","BK1161","02616","III"],"gpt_icon":0},{"id":"2613292895","title":"每日卖空追踪 | 基石药业-B 02月20日卖空量成交117.55万股，卖空比例为9.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613292895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613292895?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576231,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月20日，涨4.57%，卖空量成交117.55万股，较上一交易日增加21.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163423a4b5e8f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163423a4b5e8f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cstonepharma.com","stockEarnings":[{"period":"1week","weight":-0.0295},{"period":"1month","weight":0.1709},{"period":"3month","weight":0.1495},{"period":"6month","weight":-0.1859},{"period":"1year","weight":0.8404},{"period":"ytd","weight":0.3131}],"compareEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0074},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0294},{"period":"ytd","weight":-0.0051}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"基石药业是一家主要从事肿瘤、自身免疫和炎症及其他关键疾病领域药物研发及销售的投资控股公司。该公司通过其子公司主要从事生物制药产品的研发、药品的销售及提供其知识产权（IP）授权或商业化授权。该公司产品主要包括精准治疗药物“泰吉华”（阿伐替尼）及“普吉华”（普拉替尼）、以及“择捷美”（舒格利单抗）等。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内市场、以及中欧、东欧和瑞士等海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.050688},{"month":2,"riseRate":0.428571,"avgChangeRate":0.069097},{"month":3,"riseRate":0.25,"avgChangeRate":-0.087192},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.048094},{"month":5,"riseRate":0.5,"avgChangeRate":0.100514},{"month":6,"riseRate":0.714286,"avgChangeRate":0.09443},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05639},{"month":8,"riseRate":0.428571,"avgChangeRate":0.079119},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.071005},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.012196},{"month":11,"riseRate":0.571429,"avgChangeRate":0.010396},{"month":12,"riseRate":0.428571,"avgChangeRate":0.004524}],"exchange":"SEHK","name":"基石药业-B","nameEN":"CSTONE PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基石药业-B,02616,基石药业-B股票,基石药业-B股票老虎,基石药业-B股票老虎国际,基石药业-B行情,基石药业-B股票行情,基石药业-B股价,基石药业-B股市,基石药业-B股票价格,基石药业-B股票交易,基石药业-B股票购买,基石药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}